Literature DB >> 2336920

Influence of cardiovascular diseases upon the results of the cardiovascular reflex tests in diabetic and nondiabetic subjects.

K Krönert1, K Holder, G Kuschmierz, B Mayer, W Renn, D Luft, M Eggstein.   

Abstract

Cardiovascular reflex tests are used to assess cardiac autonomic neuropathy in diabetes mellitus. Cardiovascular diseases (CVD) are known to alter baroreflex mechanisms. Diabetic patients are at a high risk for cardiovascular complications. In order to prove whether cardiovascular diseases reduce the diagnostic value of the cardiovascular reflex tests in diabetic autonomic neuropathy unselected groups of 274 nondiabetic and 103 diabetic patients were studied: E/I, 30/15, and Valsalva ratios, sustained handgrip test and blood pressure response to standing. Both groups were subdivided into young (less than or equal to 45 years) and older (greater than 45 years) patients and into subjects with and without CVD. In young nondiabetic patients with CVD, E/I and Valsalva ratios were significantly lower than in those without CVD. In young diabetic patients with CVD, only E/I ratios were significantly reduced compared to those without CVD. The tests reflecting sympathetic nerve function did not differ between patients with and without CVD, neither in the nondiabetic nor in the diabetic subjects. In the older nondiabetic and diabetic patients, cardiovascular reflexes were generally impaired, but did not show any difference between subjects with and without CVD. In young diabetic patients suffering from CVD, the diagnostic value of cardiovascular reflex tests is reduced as far as cardiac autonomic neuropathy is concerned. In older patients, the tests are not suitable for the diagnosis of diabetic autonomic neuropathy. More specific methods are required.

Entities:  

Mesh:

Year:  1990        PMID: 2336920     DOI: 10.1007/bf02624717

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN: 0001-5563


  35 in total

1.  CIRCULATORY DYNAMICS DURING THE COLD PRESSOR TEST.

Authors:  M A GREENE; A J BOLTAX; G A LUSTIG; E ROGOW
Journal:  Am J Cardiol       Date:  1965-07       Impact factor: 2.778

2.  Effect of beta-adrenergic blockade on beat-to-beat response to Valsalva manoeuvre.

Authors:  D H Spodick; M B Meyer; V M Quarry-Pigott
Journal:  Br Heart J       Date:  1974-11

3.  Haemodynamic responses to sustained hand-grip in patients with hypertension.

Authors:  B L Hoel; E Lorentsen; P G Lund-Larsen
Journal:  Acta Med Scand       Date:  1970-12

4.  Cardiac autonomic neuropathy in diabetes: comparison of measures of R-R interval variation.

Authors:  D J Ewing; D Q Borsey; F Bellavere; B F Clarke
Journal:  Diabetologia       Date:  1981-07       Impact factor: 10.122

5.  Diagnostic value of the Valsalva ratio reduction in diabetic autonomic neuropathy: use of an age-related normal range.

Authors:  S A Smith
Journal:  Diabet Med       Date:  1984-11       Impact factor: 4.359

6.  Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts.

Authors:  M R Bristow; R Ginsburg; W Minobe; R S Cubicciotti; W S Sageman; K Lurie; M E Billingham; D C Harrison; E B Stinson
Journal:  N Engl J Med       Date:  1982-07-22       Impact factor: 91.245

7.  Comparison of myocardial catecholamine balance in chronic congestive heart failure and in angina pectoris without failure.

Authors:  K Swedberg; C Viquerat; J L Rouleau; M Roizen; B Atherton; W W Parmley; K Chatterjee
Journal:  Am J Cardiol       Date:  1984-10-01       Impact factor: 2.778

8.  The neurohumoral and hemodynamic response to orthostatic tilt in patients with congestive heart failure.

Authors:  T B Levine; G S Francis; S R Goldsmith; J N Cohn
Journal:  Circulation       Date:  1983-05       Impact factor: 29.690

9.  Reduced sinus arrhythmia in diabetic autonomic neuropathy: diagnostic value of an age-related normal range.

Authors:  S A Smith
Journal:  Br Med J (Clin Res Ed)       Date:  1982-12-04

10.  Effects of nifedipine on baroreflex modulation of vascular resistance in man.

Authors:  D W Ferguson; J K Dorsey
Journal:  Am Heart J       Date:  1985-01       Impact factor: 4.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.